Harika Atmaca

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Silver Nanoparticles

Breast Cancer Cells

Endoplasmic Reticulum Stress

Top Venues

Current topics in medicinal chemistry

Zeitschrift fur Naturforschung. C, Journal of biosciences

Molecular diversity

This page only lists publications with an associated author ORCID identifier.

Publications

Harika Atmaca, Suleyman Ilhan, Çisil Çamli Pulat, Buse Aysen Dundar, Metin Zora
Evaluation of Novel Spiro-pyrrolopyridazine Derivatives as Anticancer Compounds: In Vitro Selective Cytotoxicity, Induction of Apoptosis, EGFR Inhibitory Activity, and Molecular Docking Analysis. ACS omega 9 (22) (2024)
Suleyman Ilhan, Ferdi Oguz, Harika Atmaca
A New Approach to Melanoma Treatment: microRNAs. Current topics in medicinal chemistry 24 (16) (2024)
Harika Atmaca, Ferdi Oguz, Suleyman Ilhan
Chitosan in cancer therapy: a dual role as a therapeutic agent and drug delivery system. Zeitschrift fur Naturforschung. C, Journal of biosciences (2024)
Harika Atmaca, Ferdi Oguz, Suleyman Ilhan
Chitosan in cancer therapy: a dual role as a therapeutic agent and drug delivery system. Zeitschrift fur Naturforschung. C, Journal of biosciences 79 (5-6) (2024)
Suleyman Ilhan, Ferdi Oguz, Harika Atmaca
A New Approach to Melanoma Treatment: microRNAs. Current topics in medicinal chemistry (2024)
Hande Karabıyık, Aslıhan Karaer Tunçay, Suleyman Ilhan, Harika Atmaca, Hayati Türkmen
Synthesis and Characterization of Piano-Stool Ruthenium(II)-Arene Complexes of Isatin Schiff Bases: Cytotoxicity and DNA Intercalation. ACS omega 9 (17) (2024)
Hande Karabıyık, Aslıhan Karaer Tunçay, Suleyman Ilhan, Harika Atmaca, Hayati Türkmen
Synthesis and Characterization of Piano-Stool Ruthenium(II)-Arene Complexes of Isatin Schiff Bases: Cytotoxicity and DNA Intercalation. ACS omega 9 (17) (2024)
Harika Atmaca, Suleyman Ilhan, Çisil Çamli Pulat, Buse Aysen Dundar, Metin Zora
Evaluation of Novel Spiro-pyrrolopyridazine Derivatives as Anticancer Compounds: In Vitro Selective Cytotoxicity, Induction of Apoptosis, EGFR Inhibitory Activity, and Molecular Docking Analysis. ACS omega 9 (22) (2024)
Suleyman Ilhan, Harika Atmaca, Elif Serel Yilmaz, Esra Korkmaz, Metin Zora
N-Propargylic β-enaminones in breast cancer cells: Cytotoxicity, apoptosis, and cell cycle analyses. Journal of biochemical and molecular toxicology (2023)
Suleyman Ilhan, Çisil Çamli Pulat, Ferdi Oguz, Hakan Bektaş, Emre Menteşe, Harika Atmaca
Design and synthesis of benzimidazole derivatives as apoptosis-inducing agents by targeting Bcl-2 protein. Molecular diversity (2022)
Harika Atmaca, Çisil Çamlı Pulat, Suleyman Ilhan
Synthesis of silver nanoparticles using Alpinia officinarum rhizome extract induces apoptosis through down-regulating Bcl-2 in human cancer cells. Biologia futura 73 (3) (2022)
Harika Atmaca, Ferdi Oğuz, Suleyman Ilhan
Trabectedin (ET-743) in prostate cancer: Endoplasmic reticulum stress-induced apoptotic effect. Andrologia 54 (11) (2022)
Harika Atmaca, Suleyman Ilhan, Elif Serel Yilmaz, Metin Zora
4-Propargyl-substituted 1H-pyrroles induce apoptosis and autophagy via extracellular signal-regulated signaling pathway in breast cancer. Archiv der Pharmazie 354 (10) (2021)
Ferdi Oguz, Harika Atmaca
mRNA as a Therapeutics: Understanding mRNA Vaccines. Advanced pharmaceutical bulletin 12 (2) (2021)